PIII · P3 Health Partners Inc.
$6.77
+0.23 (+3.44%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of the date of this Form 10-Q, we believe that our existing cash resources are not sufficient to support planned operations for at least the next year from the issuance of the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$51.19M
Shares
7.26M
Volume · Sep 30
13.48K
Avg daily vol (3M)
36.14K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.54
Open$6.77
Day$6.54–6.80
52W close$1.52–16.47
Avg vol 30d18K
Short int27K · 0.4% float · 1.2d
Short vol28%
Last earningsAug 10, 2026
DataApr 2021–Sep 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 8, 2026
Est · unconfirmed
· in 6 wks
filed Aug 10, 2026
call held Aug 10, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.50B
Trailing 12 months
Net income (TTM)
−$98.44M
Trailing 12 months
Revenue growth YoY
+8.6%
Year over year
Operating margin
-9.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$98.58M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.9%
Year over year · more shares
Price change (1Y)
-32.0%
Trailing year
Short interest
0.4%
Latest settlement · 1.2 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16 · calm
Equity put/call 0.38
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+2%
above
Price vs 50-day avg
−31%
below
RSI (14)
23
oversold
MACD trend
Negative
52-week position
34%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−28%
trailing
6-month return
+138%
trailing
YTD return
+87%
this year
Relative strength
+125%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $9 › 200d $6 — 50d above 200d
Institutional flow
Flat
0% holders QoQ · +10 funds added
Insider flow
Distributing
Net -$823.9K over 90 days · 100% sells
Short interest
Rising
0.38% of float · ▲ +5.4% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — mid 3-yr range
Squeeze score
41
elevated · 0–100
Fundamentals
Revenue growth
−3%
Y/Y
EPS growth
+16%
Y/Y
Free cash flow
$-91.2M
Balance sheet
$248.4M
net debt
Quant / Vol
risk profile
Volatility
218%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
Adjusted EBITDA
· full-year 2026
Non-GAAP
Initiated
$80M – $110M
Guided vs delivered
· last 1 settled
Total Revenues
full year 2024
guided $1.45B – $1.55B
$1.5B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+2%
Bullish
Price vs 50-day avg
−31%
Bearish
RSI (14)
23
Neutral
MACD trend
Negative
Bearish
52-week position
34%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $9 › 200d $6 — 50d above 200d
Institutional flow
Flat
0% holders QoQ · +10 funds added
Insider flow
Distributing
Net -$823.9K over 90 days · 100% sells
Short interest
Rising
0.38% of float · ▲ +5.4% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
35 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $7 · 34%
Range high $16
vs 200-day avg +2%
vs 50-day avg -31%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA (loss) non-GAAP | 80.2M | Six Months Ended June 30 | — |
| Adjusted EBITDA (loss) PMPM non-GAAP | $127 | Six Months Ended June 30 | — |
| Adjusted EBITDA PMPM non-GAAP | $173 | Q2 2026 | — |
| Adjusted operating expense non-GAAP | 56.25M | Six Months Ended June 30 | — |
| At-risk members | 105,000 | Q2 2026 | — |
| Average at-risk members | 104,800 | the three months ended June 30, 2026 filing | — |
| Medical margin non-GAAP | 171.46M | Six Months Ended June 30 | — |
| Medical margin PMPM non-GAAP | $271 | Six Months Ended June 30 | — |
| Platform support costs | $26.97M | the three months ended June 30, 2026 filing | — |
| Platform support costs as % of total operating revenue | 7% | the three months ended June 30, 2026 filing | — |
| Total lives under management | 133,000 | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PIII
this stock
P3 Health Partners Inc.
|
$51.19M | +87.4% | -2.8% | — | 0.4% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -7.5% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -11.9% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +29.6% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +16.4% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PIII | -13.0% | -27.8% | +137.8% | -27.8% | +87.4% |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | -11.8% | -27.4% | +124.8% | -27.4% | +75.3% |